Document is current
Any future updates will be listed below
-
Authors
Rademakers, Glenn
Massen, Maartje
Koch, Alexander
Draht, Muriel X.
Buekers, Nikkie
Wouters, Kim A. D.
Vaes, Nathalie
De Meyer, Tim
Carvalho, Beatriz
Meijer, Gerrit A.
Herman, James G.
Smits, Kim M.
van Engeland, Manon
Melotte, Veerle https://orcid.org/0000-0002-9459-123X
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (UM-2-13-6075)
SU2C-DCS International Translational Cancer Research Dream Team Grant (Stand Up To Cancer (SU2C)-AACR- DT1415, MEDOCC)
- License Information
-
More Information
Article History
Received: 5 March 2021
Accepted: 4 April 2021
First Online: 15 April 2021
Declaration
:
: MvE is cofounder and shareholder of Epify BV, a molecular diagnostics company which develops DNA methylation markers for cancer diagnosis and personalized treatment.
